The Nrf2-GPX4 Pathway Provides Protection Against Rheumatoid Arthritis via Inhibition of Macrophage Ferroptosis-Mediated Inflammation and Synovial Fibroblast Proliferation.

Researchers have discovered a promising new understanding of how rheumatoid arthritis (RA) develops and progresses. This study examined a protective pathway in the body called Nrf2-GPX4 and how it relates to inflammation and abnormal cell growth in RA. Using laboratory rats with induced arthritis, scientists found that activating this protective pathway with a compound called CDDO-EA significantly reduced joint inflammation and damage. The pathway works by preventing a specific type of cell death called ferroptosis in immune cells called macrophages, which are key drivers of RA inflammation. When these macrophages undergo ferroptosis, they release inflammatory substances that worsen arthritis symptoms and cause the synovial cells lining the joints to multiply abnormally. By activating the Nrf2-GPX4 pathway, researchers observed decreased levels of inflammatory markers like TNF-α and IL-6, reduced oxidative stress, and less abnormal cell proliferation in joint tissue. The treatment improved multiple measures of arthritis severity in the animal model. For patients with RA who are exploring complementary treatment options, this research suggests that therapies targeting oxidative stress and inflammation—areas where acupuncture has shown benefits in clinical studies—may work through similar protective mechanisms. Acupuncture has been studied for its anti-inflammatory effects and ability to modulate immune responses, which may complement conventional RA treatments. If you're considering acupuncture for rheumatoid arthritis management, consult with a licensed acupuncturist experienced in treating autoimmune and inflammatory conditions.

This preclinical study investigated the Nrf2-GPX4 pathway's role in rheumatoid arthritis pathogenesis using complete Freund's adjuvant (CFA)-induced adjuvant-induced arthritis (AIA) in rats. Researchers found significantly downregulated Nrf2 and GPX4 protein expression in synovial tissues of arthritic rats. Treatment with Nrf2 activator CDDO-EA inhibited macrophage ferroptosis and M1 polarization while suppressing RASF proliferation. This resulted in decreased inflammatory markers (5-HT, TNF-α, IL-6), reduced oxidative stress indicators (MDA, Fe2+, lipid peroxidation), and increased antioxidant markers (SOD, GSH). In vitro studies confirmed that Nrf2-GPX4 activation arrested macrophage ferroptosis and restrained RASF proliferation, effects partially reversed by ferroptosis inducer RSL-3. Clinical relevance: This study identifies macrophage ferroptosis as a novel therapeutic target in RA pathogenesis. The findings suggest that modulating oxidative stress and ferroptotic pathways may reduce synovial inflammation and fibroblast proliferation. Acupuncture's documented anti-inflammatory and antioxidant effects may intersect with these mechanisms, supporting its use as adjunctive therapy in RA management.